Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Björn Meijers

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Clinical Kidney Journal|July 4, 2025
The CALCIPHYX trial and its impact on calciphylaxis treatment: what's next?Marieta Theodorakopoulou, Björn Meijers
Artificial Organs|July 6, 2013
Safety issues related to fractionated plasma separation, adsorption, and dialysisBjörn Meijers, Pieter Evenepoel
Seminars in Nephrology|January 10, 2024
Anticoagulation for Hemodialysis: A Hidden Quest to Ensure Safe DialysisKarlien François, Björn Meijers
Kidney International|January 16, 2010
Targeting hyperphosphatemia: truth or dareBjörn Meijers, Pieter Evenepoel
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2014
The hype cycle for soluble urokinase receptor in FSGS: passing the trough of disillusionment?Björn Meijers, Ben Sprangers
Journal of the American Society of Nephrology : JASN|June 9, 2016
HEMO Revisited: Why Kt/Vurea Only Tells Part of the StoryBjörn Meijers, Raymond Vanholder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 2, 2020
The clinical characteristics of coronavirus-associated nephropathyBjörn Meijers, Luuk B Hilbrands
Transplantation|July 16, 2013
suPAR and FSGS: the gap between bench and bedsideMaarten Naesens, Björn Meijers, Ben Sprangers
Seminars in Dialysis|March 6, 2013
The colon: an overlooked site for therapeutics in dialysis patientsRuben Poesen, Björn Meijers, Pieter Evenepoel
Pediatric Nephrology (Berlin, Germany)|November 17, 2016
The gut-kidney axisPieter Evenepoel, Ruben Poesen, Björn Meijers
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Clinical Kidney Journal|July 4, 2025
The CALCIPHYX trial and its impact on calciphylaxis treatment: what's next?Marieta Theodorakopoulou, Björn Meijers
Artificial Organs|July 6, 2013
Safety issues related to fractionated plasma separation, adsorption, and dialysisBjörn Meijers, Pieter Evenepoel
Seminars in Nephrology|January 10, 2024
Anticoagulation for Hemodialysis: A Hidden Quest to Ensure Safe DialysisKarlien François, Björn Meijers
Kidney International|January 16, 2010
Targeting hyperphosphatemia: truth or dareBjörn Meijers, Pieter Evenepoel
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2014
The hype cycle for soluble urokinase receptor in FSGS: passing the trough of disillusionment?Björn Meijers, Ben Sprangers
Journal of the American Society of Nephrology : JASN|June 9, 2016
HEMO Revisited: Why Kt/Vurea Only Tells Part of the StoryBjörn Meijers, Raymond Vanholder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 2, 2020
The clinical characteristics of coronavirus-associated nephropathyBjörn Meijers, Luuk B Hilbrands
Transplantation|July 16, 2013
suPAR and FSGS: the gap between bench and bedsideMaarten Naesens, Björn Meijers, Ben Sprangers
Seminars in Dialysis|March 6, 2013
The colon: an overlooked site for therapeutics in dialysis patientsRuben Poesen, Björn Meijers, Pieter Evenepoel
Pediatric Nephrology (Berlin, Germany)|November 17, 2016
The gut-kidney axisPieter Evenepoel, Ruben Poesen, Björn Meijers
Pageof 11